The U.S. Food and Drug Administration has granted accelerated approval for Genmab's Epkinly (epcoritamab-bysp) for relapsed or refractory diffuse large B-cell lymphoma (DLBCL), including DLBCL arising from indolent lymphoma, ...
May 23, 2023
0
12
Transthyretin-related cardiac amyloidosis is a progressive disease characterized by the deposition of amyloid protein fibrils in the heart. Amyloid fibril deposition thickens and stiffens the heart walls, and the disease ...
May 20, 2023
0
87
Researchers at Karolinska Institutet in Sweden have found further evidence for how the Epstein-Barr virus can trigger multiple sclerosis or drive disease progression. A new study published in Science Advances shows that some ...
May 17, 2023
0
113
Advanced or metastatic estrogen receptor-positive (ER+) breast cancer is commonly treated with drugs that block the estrogen receptor. However, estrogens that stimulate the receptor can also be effective. Building on their ...
May 15, 2023
0
35
Fresh insights into the spread of damaging proteins that build up in the brains of people with Alzheimer's disease could hold the key to stopping the condition from progressing, a study says.
May 15, 2023
0
83
Researchers from the University of California, Irvine have found that exposure to traffic-related air pollution in Irvine led to memory loss and cognitive decline and triggered neurological pathways associated with the onset ...
May 11, 2023
0
11
For individuals with depression, the most common causes of hospitalization are endocrine, musculoskeletal, and vascular diseases, according to a study published online May 3 in JAMA Psychiatry.
May 5, 2023
0
4
Treatment with trifluridine-tipiracil (FTD-TPI) plus bevacizumab yields longer overall survival than FTD-TPI alone among patients with refractory metastatic colorectal cancer, according to a study published in the May 4 issue ...
May 4, 2023
0
2
A new study led by Cláudia C. Faria, researcher in the lab of João Taborda Barata at the Instituto de Medicina Molecular João Lobo Antunes (iMM, Lisbon) and neurosurgeon at the Centro Hospitalar Universitário Lisboa Norte ...
May 1, 2023
0
3
Scientists at Trinity College Dublin today announced a significant development toward a new therapeutic treatment of glaucoma.
Apr 19, 2023
0
167
